Synapse - Dan Douer

Results (87)

Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy

Journal Article

Glass, J. L.; Derkach, A.; Hilden, P.; King, A.; Seo, S. K.; Ahr, K.; Kishtagari, A.; Levine, R. L.; Tallman, M. S.; Douer, D.
Leukemia Research (2021)

Fulltext@MSK | Save

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia

Journal Article

Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Vemuri, S.; Flynn, J.; Hsu, M.; Devlin, S. M.; Roshal, M.; Gao, Q.; Shukla, M.; more...
Haematologica (2021)

Fulltext@MSK | Save

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial

Journal Article

Ganzel, C.; Wang, X. V.; Rowe, J. M.; Richards, S. M.; Buck, G.; Marks, D. I.; Litzow, M. R.; Paietta, E. M.; Foroni, L.; Luger, S. M.; more...
British Journal of Haematology (2020)

Fulltext@MSK | Save

Ruxolitinib in combination with dasatinib and dexamethasone is an active and well-tolerated chemotherapy-sparing oral induction regimen for adults with Philadelphia chromosome-positive ALL: Results of a phase I trial

Meeting Abstract

Geyer, M. B.; Burke, P. W.; King, A. C.; Mauro, M. J.; Tallman, M. S.; Levine, R. L.; Sherr, C. J.; Douer, D.; Park, J. H.
Blood (2018)

Fulltext@MSK | Save

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of MRD negativity in adults ages 18-60 with Philadelphia chromosome-negative acute lymphoblastic leukemia and lymphoblastic lymphoma

Meeting Abstract

Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Cazacu, M. I.; Vemuri, S.; Tallman, M. S.; Douer, D.; Park, J. H.
Blood (2018)

Fulltext@MSK | Save

Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience

Journal Article

Ganzel, C.; Sun, Z.; Cripe, L. D.; Fernandez, H. F.; Douer, D.; Rowe, J. M.; Paietta, E. M.; Ketterling, R.; O'Connell, M. J.; Wiernik, P. H.; more...
American Journal of Hematology (2018)

Fulltext@MSK | Save

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia

Journal Article

Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
Blood Advances (2018)

Fulltext@MSK | Save

Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis

Journal Article

Geyer, M. B.; Hsu, M.; Devlin, S. M.; Tallman, M. S.; Douer, D.; Park, J. H.
Blood (2017)

Fulltext@MSK | Save

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era

Journal Article

Mantha, S.; Goldman, D. A.; Devlin, S. M.; Lee, J. W.; Zannino, D.; Collins, M.; Douer, D.; Iland, H. J.; Litzow, M. R.; Stein, E. M.; more...
Blood (2017)

Fulltext@MSK | Save

A case of acute myeloid leukemia with e6a2 BCR-ABL fusion transcript acquired after progressing from chronic myelomonocytic leukemia

Journal Article

Yao, J.; Douer, D.; Wang, L.; Arcila, M. E.; Nafa, K.; Chiu, A.
Leukemia Research Reports (2017)

Fulltext@MSK | Save